Anh-Alisse Selissen - Clinical Support Specialist - Evaheart, Inc. | LinkedIn
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Features & Benefits — Rotary pump yet pulsatile
Choosing the appropriate left ventricular assist device for your patient. - Abstract - Europe PMC
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS - The Journal of Heart and Lung Transplantation
The Next Wave of Mechanical Circulatory Support Devices - Cardiac Interventions Today
Evaheart - Crunchbase Company Profile & Funding
The Long and Winding Road to an Effective Left Ventricular Assist Device: The Demise of Medtronic's HVAD | Circulation
Hayden man is first outside Japan to receive new heart implant - News | UAB
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Study on Visualization of Ventricular Assist Device Development Process using System Dynamics
EVAHEART Left Ventricular Assist System (LVAS) for Heart Failure Clinical Trial 2022 | Power
New era for therapeutic strategy for heart failure: Destination therapy by left ventricular assist device - ScienceDirect
Centrifugal LVAS — Rotary pump yet pulsatile
Health Management and Leadership Portal | Ventricular assist device EVAHEART MEDICAL USA, Inc. | HealthManagement.org
Evaheart Clinical Trial at Penn State Health - YouTube
Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD | DAIC
New era for therapeutic strategy for heart failure: Destination therapy by left ventricular assist device - ScienceDirect
In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices - ScienceDirect
Methodist Hospital first in nation to implant newly designed cardiac mechanical pump | Methodist Healthcare
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
EVAHEART Left Ventricular Assist System (LVAS) for Heart Failure Clinical Trial 2022 | Power
In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices - The Journal of Thoracic and Cardiovascular Surgery
